Infertility is a complex condition caused by a combination of genetic, environmental, and lifestyle factors. Recent advances in epigenetics have highlighted the importance of epigenetic changes in fertility regulation. This review aims to provide a comprehensive overview of the epigenetic mechanisms involved in infertility, with a focus on DNA methylation, histone modification, and non-coding RNAs. We investigate the specific epigenetic events that occur during gametogenesis, with a focus on spermatogenesis and oogenesis as distinct processes. Furthermore, we investigate how environmental factors such as diet, stress, and toxin exposure can influence these epigenetic changes, potentially leading to infertility. The second part of the review explores epigenetic changes as therapeutic targets for infertility. Emerging therapies that modulate epigenetic marks present promising opportunities for fertility restoration, particularly in spermatogenesis. By summarizing current research findings, this review emphasizes the importance of understanding epigenetic contributions to infertility. Our discussion aims to lay the groundwork for future research directions and clinical applications in reproductive health.

Lung cancer is a complex disease, and many factors, including environmental and occupational exposure, cigarette smoking, and genetics, contribute to its progression. Angiotensin-converting enzyme (ACE) is an important regulator of blood pressure and cardiovascular homeostasis. Plasma levels of ACE depend on an insertion/deletion (I/D) polymorphism in its gene. Current correlation data between lung cancer and the ACE I/D polymorphism are contradictory or insufficient. We investigated whether the ACE I/D polymorphism is associated with a risk for lung cancer development in the Croatian population, representing the first report in a population of Slavic origin. A total of 308 lung cancer patients and 353 control subjects were genotyped for the ACE I/D polymorphism by polymerase chain reaction. The observed distribution of genotypes and alleles showed no significant difference between total patients and controls ( p >0.050). However, in a subgroup of nonsmall cell lung cancer patients with squamous cell carcinoma, a significantly higher frequency of the DD genotype (37.7% vs. 27.8%, p =0.030, OR=1.57, 95% CI=1.05-2.36) and D allele was observed compared with the control group (61.3% vs. 52.8%, p =0.015, OR=1.41, 95% CI=1.07-1.87). The DD genotype of ACE may contribute to a higher risk of developing squamous cell carcinoma in the Croatian population.

Epigenetic biomarkers, such as DNA methylation, histone alterations, and non-coding RNAs, are increasingly recognized as essential instruments in disease diagnoses, prognostics, and customized therapy. As their clinical significance increases, so does the necessity for robust, interpretable, and scalable techniques that can accurately detect these molecular alterations. This review provides a critical and organized overview of contemporary technologies employed to characterize the principal categories of epigenetic modifications, encompassing PCR- and sequencing-based methods, high-resolution immunoprecipitation techniques, and CRISPR-enhanced detection systems. Although numerous procedures are technically well-established, their implementation outside research laboratories frequently faces substantial challenges: elevated prices, data intricacy, absence of standardization, and restricted translational frameworks. Furthermore, the interpretation of epigenetic data continues to pose a significant difficulty, especially for heterogeneous clinical samples and the swiftly advancing computational techniques. We examine the advantages and drawbacks of existing approaches, focusing on their incorporation into biomedical engineering platforms, including biosensors, lab-on-a-chip devices, and AI-assisted diagnostics. This review seeks to assist researchers, physicians, and engineers in choosing suitable technologies, comprehending their limitations, and pinpointing areas requiring urgent innovation by merging analytical rigor with a pragmatic viewpoint.